Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

A discriminative analytical method for detection of CES1A1 and CES1A2/CES1A3 genetic variants.

Zhu HJ, Brinda B, Froehlich TE, Markowitz JS.

Pharmacogenet Genomics. 2012 Mar;22(3):215-8. doi: 10.1097/FPC.0b013e32834f03eb.

2.

Carboxylesterase 1 genes: systematic review and evaluation of existing genotyping procedures.

Rasmussen HB, Madsen MB; INDICES Consortium.

Drug Metab Pers Ther. 2018 Mar 28;33(1):3-14. doi: 10.1515/dmpt-2017-0023. Review.

PMID:
29427553
3.

Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics.

Rasmussen HB, Bjerre D, Linnet K, Jürgens G, Dalhoff K, Stefansson H, Hankemeier T, Kaddurah-Daouk R, Taboureau O, Brunak S, Houmann T, Jeppesen P, Pagsberg AK, Plessen K, Dyrborg J, Hansen PR, Hansen PE, Hughes T, Werge T; INDICES Consortium.

Pharmacogenomics. 2015;16(6):649-65. doi: 10.2217/pgs.15.7. Epub 2015 Apr 21. Review.

PMID:
25896426
4.

Investigation binding patterns of human carboxylesterase I (hCES I) with broad substrates by MD simulations.

Chu H, Min H, Zhang M, Shen H, Li G.

Curr Top Med Chem. 2013;13(10):1222-33. Review.

PMID:
23647544
5.

[Progress in the structure and function of human carboxylesterase 1].

Tong J, Yi Y, Cao P, Liu C, Wang L, Lü Y.

Sheng Wu Gong Cheng Xue Bao. 2012 Dec;28(12):1414-22. Review. Chinese.

PMID:
23593865

Supplemental Content

Support Center